SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Disco Pharmaceuticals Gives AbbVie Option to License Selected Programs

After specified research is completed, AbbVie will have the option to exclusively license selected programs for further development.

ABBV

Related stories